S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 AI Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How Biden has already won 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ACST Stock Alerts
C$0.58
+0.01 (+1.75%)
(As of 03/27/2023)
Compare
Today's Range
C$0.56
▼
C$0.58
50-Day Range
C$0.58
▼
C$0.58
52-Week Range
C$0.47
▼
C$1.66
Volume
2,450 shs
Average Volume
6,576 shs
Market Capitalization
C$25.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ACST stock logo

About Acasti Pharma Stock (CVE:ACST)

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

ACST Stock Price History

ACST Stock News Headlines

April 6, 2024 | finance.yahoo.com
Acasti Pharma Inc. (ACST)
March 14, 2024 | edition.cnn.com
Acasti Pharma Inc. Class A
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 25, 2024 | msn.com
Acasti Pharma (ACST) Price Target Increased by 200.00% to 6.12
February 12, 2024 | finance.yahoo.com
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
December 25, 2023 | finance.yahoo.com
Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
November 14, 2023 | investing.com
Acasti Pharma (ACST) Earnings Dates & Reports
November 11, 2023 | morningstar.com
Acasti Pharma Inc Class A ACST
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
September 26, 2023 | benzinga.com
Why Acasti Pharma (ACST) Stock Is Exploding Higher
September 6, 2023 | technews.tmcnet.com
Acasti to Participate in the H.C. Wainwright Global Investment Conference
August 11, 2023 | finanznachrichten.de
Acasti Pharma, Inc.: Acasti Announces First Quarter 2024 Financial Results and Business Highlights
June 23, 2023 | finanznachrichten.de
Acasti Pharma Inc.: Acasti Pharma Reports Fiscal Year 2023 Operational Results
June 23, 2023 | finance.yahoo.com
Acasti Pharma Reports Fiscal Year 2023 Operational Results
June 22, 2023 | finance.yahoo.com
Acasti Announces Appointment of New Scientific Advisory Board Members
June 20, 2023 | sg.finance.yahoo.com
ACST - Acasti Pharma Inc.
April 7, 2023 | theglobeandmail.com
Closing Bell: Acasti Pharma Inc up on Monday (ACST)
April 4, 2023 | seekingalpha.com
Acasti Pharma announces CEO transition
March 16, 2023 | morningstar.com
Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange | Morningstar
March 8, 2023 | finance.yahoo.com
Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conference
March 4, 2023 | finance.yahoo.com
We're Hopeful That Acasti Pharma (CVE:ACST) Will Use Its Cash Wisely
March 1, 2023 | finance.yahoo.com
Acasti Pharma Recognizes Rare Disease Day
February 28, 2023 | msn.com
Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year?
January 13, 2023 | benzinga.com
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
November 15, 2022 | seekingalpha.com
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript
November 9, 2022 | it.tmcnet.com
Acasti Pharma to Present at Q4 Investor Summit
November 8, 2022 | tmcnet.com
Acasti Pharma to Report Second Quarter 2023 Financial
See More Headlines
Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:ACST
Previous Symbol
CVE:APO
CUSIP
N/A
CIK
N/A
Web
www.acastipharma.com
Phone
+1-450-6864555
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-17,250,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-16.60%
Return on Assets
-8.25%

Debt

Debt-to-Equity Ratio
0.52
Current Ratio
9.74
Quick Ratio
9.41

Sales & Book Value

Annual Sales
C$115,000.00
Price / Sales
224.99
Cash Flow
C$0.93 per share
Price / Cash Flow
0.63
Book Value
C$2.17 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
44,610,000
Free Float
N/A
Market Cap
C$25.87 million
Optionable
Not Optionable
Beta
1.22
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Ms. Janelle D'Alvise (Age 68)
    Pres, CEO, Corp. Sec. & Director
    Comp: $620.16k
  • Dr. Pierre Lemieux M.D. (Age 58)
    Ph.D., Co-Founder, COO & Chief Scientific Officer
    Comp: $398.75k
  • Mr. Brian D. Ford CPA (Age 64)
    CA, Chief Financial Officer
    Comp: $340.84k
  • Dr. George Kottayil (Age 60)
    Chief Operating Officer of US
    Comp: $160.16k
  • Mr. Prashant Kohli
    Chief Commercial Officer
  • Dr. Yves Lachance Ph.D.
    VP of Quality & Compliance
  • Ms. Christine Pelletier
    Sr. Director of HR

Key Competitors

View All Competitors

ACST Stock Analysis - Frequently Asked Questions

How have ACST shares performed in 2024?

Acasti Pharma's stock was trading at C$0.58 at the beginning of 2024. Since then, ACST shares have increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Acasti Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB), Aurora Cannabis (ACB), SCYNEXIS (SCYX), Block (SQ), Nokia Oyj (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).

How do I buy shares of Acasti Pharma?

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ACST) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden replacement revealed?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends